Scrub Typhus Clinical Trial
Official title:
Controlled Trial: 5-day Course of Rifampin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus
New antibiotics are required to have not only the antibacterial activity against
doxycyline-resistant O. tsutsugamushi but also lower risk for resistance or any
cross-resistance to others.
In this prospective, open-label, randomized trial, we enroll patients with mild-to-moderate
scrub typhus. We compared the efficacy and safety of a 5-day rifampin therapy with those of a
5-day doxycycline therapy at Chosun University Hospital, or one of its two community-based
affiliated hospitals which are all located in southwestern Korea between 2006 and 2009.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00351182 -
Controlled Trial: 5-day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus
|
Phase 3 | |
Completed |
NCT03274869 -
Scrub Typhus Infection Induced Cardiovascular Disease
|
||
Completed |
NCT02876367 -
The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents
|
||
Recruiting |
NCT03083197 -
Scrub Typhus Antibiotic Resistance Trial
|
Phase 4 | |
Completed |
NCT02915861 -
Eschar Investigations in Scrub Typhus
|
||
Completed |
NCT02398162 -
Scrub Typhus Pediatric Immunology Study
|
||
Completed |
NCT04506944 -
The Epidemiology of Rickettsial Infections in South India: Cohort Study
|